Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/20/2014US20140079728 Adjuvanting material
03/20/2014US20140079726 Influenza hemagglutinin and neuraminidase variants
03/20/2014US20140079720 Inhibitors of extracellular hsp90
03/20/2014US20140079713 Modulation of the sonic hedgehog pathway and uses thereof
03/20/2014US20140079712 Therapeutic Applications Targeting SARM1
03/20/2014US20140079710 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
03/20/2014US20140079706 Combination therapy of antibodies against human csf-1r and uses thereof
03/20/2014US20140079704 BI-Specific Diabodies For Masking And Targeting Vaccines
03/20/2014US20140079703 Combination therapies comprising anti-erbb3 agents
03/20/2014US20140079702 Antagonists of il-6 to raise albumin and/or lower crp
03/20/2014US20140079699 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/20/2014US20140079696 Method of increasing the effect of an activated-potentiated form of an antibody
03/20/2014US20140079695 Preventive agent for vasculitis
03/20/2014US20140079694 Cai-based systems and methods for the localized treatment of ocular and other diseases
03/20/2014US20140079692 Dosages for treatment with anti-egfr antibodies
03/20/2014US20140079690 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
03/20/2014US20140079665 Therapeutic anti-igf1r combinations
03/20/2014US20140079642 Nanoparticles based for dermal and systemic delivery of drugs
03/20/2014US20140079637 Methods and compositions for improving antiangiogenic therapy with anti-integrins
03/20/2014US20140079628 Anti-tissue factor antibodies and compositions
03/19/2014EP2708560A1 Antibody specifically recognising transferrin receptor
03/19/2014EP2708559A2 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
03/19/2014EP2708558A2 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
03/19/2014EP2708549A2 Improved vaccines and methods for using the same
03/19/2014EP2708242A2 Uses and compositions for treatment of ankylosing spondylitis
03/19/2014EP2708241A1 Recombinant Fc-fusion protein of the two Immunoglobulin domains of UNC5
03/19/2014EP2708240A1 Treatment of tail necrosis
03/19/2014EP2708239A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
03/19/2014EP2708238A1 Cytotoxic t cell inducer
03/19/2014EP2708237A1 Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii
03/19/2014EP2708234A1 Tetraspanin CD82 as a diagnostic and/or therapeutic module for xenograft recognition and/or rejection
03/19/2014EP2708231A1 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
03/19/2014EP2707480A1 Virus-like particles and process for preparing same
03/19/2014EP2707393A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
03/19/2014EP2707391A1 Antibodies against her3
03/19/2014EP2707390A1 Antibodies for treatment of cancer expressing claudin 6
03/19/2014EP2707388A2 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
03/19/2014EP2707031A2 Protein-active agent conjugates and method for preparing the same
03/19/2014EP2707030A1 Cancer treatments
03/19/2014EP2707029A1 Methods of treating or preventing cholesterol related disorders
03/19/2014EP2707028A1 c-KIT ANTIBODIES AND USES THEREOF
03/19/2014EP2707027A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
03/19/2014EP2707026A1 Production of dense bodies (db) from hcmv-infected cells
03/19/2014EP2707025A1 Hendra and nipah virus g glycoprotein immunogenic compositions
03/19/2014EP2707024A1 Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
03/19/2014EP2707023A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
03/19/2014EP2707022A1 Molecule for treating an inflammatory disorder
03/19/2014EP2707020A1 Compositions and methods for treating cancer
03/19/2014EP2706991A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014CN1938046B Monomethylvaline compounds capable of conjugation to ligands
03/19/2014CN103649320A Recombinant vaccine against prrs in a viral vector
03/19/2014CN103649316A A synthetic hepatitis c genome and methods of making and use
03/19/2014CN103649315A Hypoallergen
03/19/2014CN103649306A Natural derivative of the lactobacilus johnsonii strain cncm I-1225, deficient in d-lactic acid production and with a further improved immune profile
03/19/2014CN103649123A Antibodies against G-CSFR and uses thereof
03/19/2014CN103649118A Bispecific binding agents
03/19/2014CN103649114A Novel immunoconjugates
03/19/2014CN103649110A R2R1/2 in diagnosis and therapy
03/19/2014CN103648587A Vaccine delivery method
03/19/2014CN103648531A Method for prevention or treatment of metabolic syndrome
03/19/2014CN103648530A Protein-active agent conjugates and method for preparing the same
03/19/2014CN103648529A Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for potential adverse effects
03/19/2014CN103648528A Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
03/19/2014CN103648527A Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)
03/19/2014CN103648526A Group a streptococcus multivalent vaccine
03/19/2014CN103648525A Recombinant immunotoxin targeting mesothelin
03/19/2014CN103648524A Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
03/19/2014CN103648523A Compositions and methods for treating cancer
03/19/2014CN103648513A Yeast-brachyury immunotherapeutic compositions
03/19/2014CN103648489A Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014CN103642898A Mutations in oas1 genes
03/19/2014CN103642815A Recombinant lactococcus lactis for secreting and expressing Dermatophagoides pteronyssinus allergen Derp2 and application of recombinant lactococcus lactis
03/19/2014CN103642814A Recombinant lactococcus lactis for anchoring expression of dermatophagoides pteronyssinus allergen Derp2 and application thereof
03/19/2014CN103642813A Recombinant lactococcus lactis of intracellular expression dermatophagoides pteronyssinus allergen Derp2 and application thereof
03/19/2014CN103642792A Preparation and application of neutralizing monoclonal antibody of anti-hepatitis C virus
03/19/2014CN103642761A Respiratory syncytial virus-like particles and preparation method and application thereof
03/19/2014CN103642759A Recombined infectious bronchitis virus embedded with IBV 4/91 strain spike protein ectodomain gene fragment, construction method and application of virus
03/19/2014CN103642758A Recombinant baculovirus expressing novel duck reovirus outer capsid proteins and construction method thereof
03/19/2014CN103642757A Bluetongue virus NS2 protein monoclonal antibody BTV-4D4, B cell epitope recognized thereby and applications
03/19/2014CN103642746A Recombinant lactococcus lactis for intracellular expression of peanut allergen and application thereof
03/19/2014CN103641920A Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (PRRSV) and uses thereof
03/19/2014CN103641917A Anti-CD26 antibody and application thereof
03/19/2014CN103641916A Binding member for gm-csf receptor
03/19/2014CN103641915A Binding member for GM-CSF receptor
03/19/2014CN103641898A Novel immunoadjuvant flagellin-based compounds and use thereof
03/19/2014CN103641885A Protein purification by ion exchange chromatography
03/19/2014CN103638521A Nerve elongation promoter and elongation inhibitor
03/19/2014CN103638520A Uses of vaccine adjuvants of saikoside a and saikoside d
03/19/2014CN103638519A Preparation of anti-influenza virus
03/19/2014CN103638518A Heptapeptide mixture and application of heptapeptide in preparation of Coxiella burnetii vaccine
03/19/2014CN103638517A Special-purpose kit for preparing human dendritic cell vaccines
03/19/2014CN102911285B Process for refining group C/Y/W135 meningococcal polysaccharides
03/19/2014CN102839159B CoxA16 virus strain and human CoxA16 inactivated vaccine
03/19/2014CN102836424B Vaccine for preventing and treating scars and preparation method thereof
03/19/2014CN102824634B Recombined Swinepox virus carrier vaccine capable of expressing porcine circovirus 2-type Cap protein and preparation method thereof
03/19/2014CN102802663B Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
03/19/2014CN102462840B Therapeutic hepatitis B vaccine
03/19/2014CN102458478B Albumin-amyloid peptide conjugates and uses thereof
03/19/2014CN102458462B A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
03/19/2014CN102199204B Chicken-origin heat shock protein, and encoding gene and application thereof
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 1823